Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Bohn

Showing results (151-160 of 289) with videos related to

Pageof 29
Sort By:
EFSA Journal. European Food Safety Authority|September 22, 2025
Beta-glucans from oats or barley and reduction of postprandial glycaemic responses: Modification of an authorised health claim pursuant to Article 13(1) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
BMC Medical Research Methodology|February 6, 2019
Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) studyAla'a Alkerwi, Jessica Pastore, Nicolas Sauvageot, et al.
Journal of Personalized Medicine|December 24, 2025
Empowering Healthy Lifestyle Behavior Through Personalized Intervention Portfolios Using a Healthy Lifestyle Recommender System to Prevent and Control Obesity in Young Adults: Pilot Study Protocol from the HealthyW8 ProjectSilvia García, Marina Ródenas-Munar, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|March 6, 2025
Nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk and whey protein concentrates and used in infant and follow-on formula manufactured from hydrolysed protein by Healthcare Reckitt B.V, Torsten Bohn, Montaña Cámara, et al.
EFSA Journal. European Food Safety Authority|January 23, 2025
Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co-operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow-on formula, Torsten Bohn, Montaña Cámara, et al.
EFSA Journal. European Food Safety Authority|April 25, 2022
Scientific advice related to nutrient profiling for the development of harmonised mandatory front-of-pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|October 28, 2021
Organic foods and contribution to the protection of body cells and molecules (lipids and DNA) from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|October 28, 2021
Isomaltulose and normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
Frontiers in Molecular Biosciences|March 5, 2021
Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?Candice Trocmé, Nicolas Gonnet, Margaux Di Tommaso, et al.
EFSA Journal. European Food Safety Authority|July 5, 2024
Joselito® and lowering of LDL-cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
Pageof 29

Showing results (151-160 of 289) with videos related to

Sort By:
Pageof 29
EFSA Journal. European Food Safety Authority|September 22, 2025
Beta-glucans from oats or barley and reduction of postprandial glycaemic responses: Modification of an authorised health claim pursuant to Article 13(1) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
BMC Medical Research Methodology|February 6, 2019
Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) studyAla'a Alkerwi, Jessica Pastore, Nicolas Sauvageot, et al.
Journal of Personalized Medicine|December 24, 2025
Empowering Healthy Lifestyle Behavior Through Personalized Intervention Portfolios Using a Healthy Lifestyle Recommender System to Prevent and Control Obesity in Young Adults: Pilot Study Protocol from the HealthyW8 ProjectSilvia García, Marina Ródenas-Munar, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|March 6, 2025
Nutritional safety and suitability of a specific protein hydrolysate derived from sources of skimmed cow's milk and whey protein concentrates and used in infant and follow-on formula manufactured from hydrolysed protein by Healthcare Reckitt B.V, Torsten Bohn, Montaña Cámara, et al.
EFSA Journal. European Food Safety Authority|January 23, 2025
Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co-operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow-on formula, Torsten Bohn, Montaña Cámara, et al.
EFSA Journal. European Food Safety Authority|April 25, 2022
Scientific advice related to nutrient profiling for the development of harmonised mandatory front-of-pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|October 28, 2021
Organic foods and contribution to the protection of body cells and molecules (lipids and DNA) from oxidative damage: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|October 28, 2021
Isomaltulose and normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
Frontiers in Molecular Biosciences|March 5, 2021
Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?Candice Trocmé, Nicolas Gonnet, Margaux Di Tommaso, et al.
EFSA Journal. European Food Safety Authority|July 5, 2024
Joselito® and lowering of LDL-cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
Pageof 29